CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $113,000 | -30.2% | 56,003 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $162,000 | -41.1% | 59,945 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $275,000 | -15.1% | 61,739 | +10.6% | 0.00% | 0.0% |
| Q2 2021 | $324,000 | -4.4% | 55,816 | +15.5% | 0.00% | 0.0% |
| Q1 2021 | $339,000 | +46.8% | 48,335 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $231,000 | -20.1% | 48,207 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $289,000 | -3.0% | 49,591 | +12.1% | 0.00% | 0.0% |
| Q2 2020 | $298,000 | +56.8% | 44,219 | +48.4% | 0.00% | 0.0% |
| Q1 2020 | $190,000 | -42.2% | 29,804 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $329,000 | +163.2% | 31,528 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $125,000 | -72.9% | 31,792 | +2.4% | 0.00% | -50.0% |
| Q2 2019 | $462,000 | -38.7% | 31,046 | +2.3% | 0.00% | -33.3% |
| Q1 2019 | $754,000 | +33.9% | 30,362 | -3.1% | 0.00% | +50.0% |
| Q4 2018 | $563,000 | -39.3% | 31,346 | -0.8% | 0.00% | -33.3% |
| Q3 2018 | $928,000 | -34.2% | 31,587 | +1.8% | 0.00% | -40.0% |
| Q2 2018 | $1,410,000 | -4.9% | 31,018 | +10.4% | 0.01% | 0.0% |
| Q1 2018 | $1,483,000 | -26.3% | 28,090 | -5.1% | 0.01% | -28.6% |
| Q4 2017 | $2,013,000 | -15.9% | 29,600 | +1.9% | 0.01% | -12.5% |
| Q3 2017 | $2,393,000 | +4.7% | 29,044 | +19.0% | 0.01% | 0.0% |
| Q2 2017 | $2,286,000 | +61.4% | 24,416 | +9.8% | 0.01% | +60.0% |
| Q1 2017 | $1,416,000 | +74.4% | 22,235 | +21.7% | 0.01% | +66.7% |
| Q4 2016 | $812,000 | -99.9% | 18,277 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $660,616,000 | +163.2% | 18,325 | +0.2% | 0.00% | +200.0% |
| Q2 2016 | $251,035,000 | -19.5% | 18,297 | +12.4% | 0.00% | 0.0% |
| Q1 2016 | $312,000,000 | -39.5% | 16,281 | +10.5% | 0.00% | -50.0% |
| Q4 2015 | $516,000,000 | +38350.1% | 14,737 | +1.0% | 0.00% | -66.7% |
| Q3 2015 | $1,342,000 | -99.9% | 14,591 | +0.1% | 0.01% | +20.0% |
| Q2 2015 | $1,280,763,000 | +11.2% | 14,574 | -6.1% | 0.01% | 0.0% |
| Q1 2015 | $1,151,753,000 | +32.6% | 15,516 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $868,896,000 | +18.8% | 15,516 | -3.8% | 0.00% | +33.3% |
| Q3 2014 | $731,657,000 | +9.5% | 16,130 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $668,440,000 | -20.9% | 16,142 | +32.3% | 0.00% | -25.0% |
| Q1 2014 | $844,886,000 | +12.6% | 12,197 | -2.1% | 0.00% | 0.0% |
| Q4 2013 | $750,603,000 | +32.5% | 12,454 | +33.7% | 0.00% | +33.3% |
| Q3 2013 | $566,287,000 | -13.4% | 9,317 | -4.6% | 0.00% | -25.0% |
| Q2 2013 | $653,859,000 | – | 9,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |